Memphis Grizzlies forward Brandon Clarke had heroin, cocaine, morphine and multiple prescription drugs in his system when he died, according to the autopsy report released this week. Clarke was 26. The report lists the cause as mixed drug toxicity. The Grizzlies issued a statement expressing condolences to Clarke's family and declined further comment pending league review.
Clarke signed a four-year, $52 million extension in October 2022 after averaging 10.0 points and 5.5 rebounds across his first three seasons. He appeared in 18 games this season before his death in late January. The contract carries $13 million in annual salary through 2026. Under the NBA's Collective Bargaining Agreement, Clarke's remaining salary converts to dead cap—it counts against Memphis's payroll and luxury tax but produces zero minutes. The Grizzlies are already $12 million over the tax line. Clarke's $39 million in remaining guarantees pushes their repeater-tax bill north of $80 million this season alone if they make no other moves.
The autopsy creates two problems for owner Robert Pera. The first is roster construction. Clarke was the Grizzlies' primary backup center and played 22 minutes per game in their playoff rotation last spring. Memphis has 11 games before the trade deadline. They cannot use Clarke's salary in a trade—dead cap has no trade value—and they cannot sign a replacement above the veteran minimum without triggering the hard cap. The front office is calling agents for available bigs on ten-day contracts. The second problem is insurance. NBA teams carry policies on guaranteed contracts, but standard coverage excludes deaths caused by illegal narcotics. If the toxicology results void the policy, Pera eats the full $39 million. The insurance carrier has 90 days to dispute the claim. Pera's team is already in discussions with counsel.
The Grizzlies' luxury-tax payment last season was $27 million. This season's bill was projected at $65 million before Clarke's death. If the insurance claim is denied and Memphis stands pat, the total approaches $105 million—tax plus dead salary. Pera has publicly supported aggressive spending, but the math tests that position. The franchise is valued at $2.4 billion per Forbes, but Pera bought in 2012 at $377 million and has extracted minimal cash distributions while reinvesting in payroll and a practice facility. A $105 million outlay with no roster benefit forces a decision: cut salary elsewhere or accept a nine-figure bath in a year the team was expected to contend.
The league office has opened a standard review of the circumstances. Commissioner Adam Silver has discretion to impose team penalties if the investigation reveals negligence in player care or ignored red flags. The Grizzlies' medical and performance staff has not been implicated, but the review will examine Clarke's health records, drug-testing history, and any missed warnings. The Players Association will participate. Results are expected by late March, two weeks after the insurance dispute deadline.
Clarke's agents at CAA declined comment. His family released a statement asking for privacy. The Grizzlies play 32 games after the trade deadline. Their current backup center rotation is Santi Aldama at 18 minutes per game and two-way player Kenneth Lofton Jr., who has appeared in 4 NBA games this season. The front office has until February 8 to add a trade piece or commit to internal options. Pera's willingness to pay the tax without Clarke's production will signal whether Memphis remains a win-now operation or begins shedding contracts.
The next deadline is the insurance carrier's response, due in 90 days. After that, the Grizzlies know whether they're eating $39 million or getting a check. The roster decision happens first.